HAEMONETICS CORP·4

Nov 13, 5:17 PM ET

MEELIA RICHARD J 4

4 · HAEMONETICS CORP · Filed Nov 13, 2019

Insider Transaction Report

Form 4
Period: 2019-11-11
Transactions
  • Exercise/Conversion

    Common Stock

    2019-11-11$45.45/sh+6,573$298,74336,640 total
  • Exercise/Conversion

    Non-qualified Stock Option (Right to Buy)

    2019-11-116,5730 total
    Exercise: $45.45From: 2014-07-24Exp: 2020-07-24Common Stock (6,573 underlying)
  • Sale

    Common Stock

    2019-11-11$118.15/sh6,573$776,60030,067 total
Footnotes (3)
  • [F1]This number includes unvested restricted stock units previously reported.
  • [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $118.00 to $118.64, inclusive. the reporting person undertakes to provide to Haemonetics Corporation ("Haemonetics"), any security holder of Haemonetics, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2) to this Form 4.
  • [F3]Grant to reporting person of right to buy shares of common stock exercisable 100 percent on the first anniversary of the date of grant.

Documents

1 file
  • 4
    form4.xmlPrimary

    PRIMARY DOCUMENT